KLOW

Batch #: KLOW-50101010-601
Verified Potency: 62.22mg / 12.48mg / 11.29mg / 11.01mg
$275.00

KLOW is a four-peptide regenerative blend combining BPC-157, TB-500, KPV and GHK-CU for research focused on cellular repair, inflammation pathways, and tissue remodeling.

Ships by Calculating...
Disclaimer
For Research Use Only. Not for human consumption or therapeutic treatment.

About KLOW

The KLOW blend brings together four well-studied peptides involved in inflammatory modulation, angiogenesis, cellular migration, and regenerative signaling. GHK-Cu is widely examined for its copper-mediated effects on gene expression and tissue remodeling; BPC-157 is researched for its influence on angiogenesis and gut-derived repair pathways; TB-500 (the active fragment of thymosin beta-4) is known for its role in actin regulation and cell mobility; and KPV, derived from α-MSH, is used for its potent interaction with inflammatory and immune pathways. Together, this combination allows researchers to explore synergistic effects across wound environments, cytokine signaling, and cellular restructuring models. The KLOW formulation is designed to support multi-pathway investigation into regeneration and inflammation.

Product Specifications
GHK-Cu, BPC-157, TB-500, and KPV Lyophilized Powder in 3ml vial
Application
Regeneration, inflammation, and tissue-repair pathway research
Appearance
Solid, white powder in 3mL glass ampule
Chemical Formula
GHK-Cu: C14H22CuN6O4 BPC-157: C62H98N16O22 TB-500: C212H350N56O78S KPV: C19H30N4O4
CAS number
GHK-Cu: 89030-95-5 BPC-157: 137525-51-0 TB-500: 77591-33-4 KPV: 88229-20-3
Molecular Weight
GHK-Cu: ~340.9 g/mol BPC-157: ~1419.5 g/mol TB-500: ~4963.4 g/mol KPV: ~378.5 g/mol

FAQs

What is the KLOW peptide blend?
KLOW is a multi-peptide research blend sold by Limitless Peptides that combines four compounds: KPV, GHK-Cu, BPC-157, and TB-500. It builds on the GLOW blend by adding KPV, a tripeptide derived from alpha-melanocyte-stimulating hormone that is studied for anti-inflammatory activity. The blend is formulated as a lyophilized powder in a single sealed 3mL glass ampule.
KPV adds anti-inflammatory activity through inhibition of nuclear factor kappa-B signaling. While GLOW combines GHK-Cu, BPC-157, and TB-500 for tissue remodeling and repair research, KLOW adds KPV's intracellular anti-inflammatory mechanism to the same base. This provides researchers with a four-component blend that addresses both structural tissue repair pathways and inflammatory signaling modulation in a single formulation.
KLOW is formulated for research protocols that require combined tissue remodeling and anti-inflammatory effects. The individual components target collagen synthesis and gene expression regulation (GHK-Cu), nitric oxide pathway modulation and angiogenesis (BPC-157), actin polymerization and cell migration (TB-500), and nuclear factor kappa-B inhibition (KPV). Researchers use multi-peptide blends when studying complex biological processes that involve multiple simultaneous signaling pathways.
KLOW provides all four peptides pre-blended in a single vial at fixed ratios, which reduces the number of separate reconstitutions and measurements required for combination research protocols. Purchasing the individual peptides separately allows researchers to control the concentration of each component independently and to design experiments that test single peptides or custom combinations at varying dose ratios.
Limitless Peptides sells KLOW as a lyophilized research blend in a sealed 3mL glass ampule. The product is Janoshik verified for identity, potency, and purity. KLOW is sold for research use only and is not approved for human consumption. The product page provides the certificate of analysis and a link to the independent Janoshik verification report.